Concepedia

James J. Li

JJ

Statistics

Publications

50

Citations

2K

H-Index

28

Active since

1994

Affiliations

University of Wisconsin–Madison(Current)

University of California, Los Angeles

Bristol-Myers Squibb (United States)

Monsanto (United States)

Virginia Commonwealth University

James J. Li is an author at University of Wisconsin–Madison specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1994–2024

50

Publications

50

SUPERGNOVA: local genetic correlation analysis reveals heterogeneous etiologic sharing of complex traits

Yiliang Zhang, Qiongshi Lu, Yixuan Ye et al. · Genome biology · 2021 · 179 citations · Full text

1,2-Diarylcyclopentenes as Selective Cyclooxygenase-2 Inhibitors and Orally Active Anti-inflammatory Agents

James J. Li, Gary D. Anderson, Earl G. Burton et al. · Journal of Medicinal Chemistry · 1995 · 177 citations · Full text

, , +16

Selective Cyclooxygenase Inhibitors: Novel 1,2-Diarylcyclopentenes Are Potent and Orally Active COX-2 Inhibitors

David B. Reitz, James J. Li, Monica B. Norton et al. · Journal of Medicinal Chemistry · 1994 · 118 citations · Full text

, , +19

Novel Terphenyls as Selective Cyclooxygenase-2 Inhibitors and Orally Active Anti-inflammatory Agents

James J. Li, Monica B. Norton, Emily J. Reinhard et al. · Journal of Medicinal Chemistry · 1996 · 106 citations · Full text

, , +17

2-Hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitors

James J. Li, Haixia Wang, Joseph A. Tino et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 89 citations · Full text

, , +8

1–5 of 50